博瑞医药9月22日大宗交易平台出现一笔成交，成交量2.61万股，成交金额213.50万元，大宗交易成交价 为81.80元。该笔交易的买方营业部为申万宏源证券有限公司证券投资总部，卖方营业部为国联民生证 券股份有限公司总部。 两融数据显示，该股最新融资余额为23.67亿元，近5日增加1.84亿元，增幅为8.43%。（数据宝） 9月22日博瑞医药大宗交易一览 进一步统计，近3个月内该股累计发生23笔大宗交易，合计成交金额为2.20亿元。 证券时报·数据宝统计显示，博瑞医药今日收盘价为81.80元，下跌13.15%，日换手率为8.66%，成交额 为33.19亿元，全天主力资金净流出3.67亿元，近5日该股累计下跌10.29%，近5日资金合计净流入1.91亿 元。 | 成交量 | 成交金额 | 成交价格 | 相对当日收盘折 | 买方营业部 | 卖方营业部 | | --- | --- | --- | --- | --- | --- | | （万股） | （万元） | （元） | 溢价（%） | | | | 2.61 | 213.50 | 81.80 | 0.00 | 申万宏源证券有限公司 | 国联民生证券股份有 | | ...

Market Performance - The Sci-Tech Innovation Board (STAR Market) index rose by 3.38%, closing at 1408.64 points, with a total trading volume of 4.626 billion shares and a turnover of 270.488 billion yuan, resulting in an average turnover rate of 2.46% [1] - Among the tradable stocks on the STAR Market, 363 stocks closed higher, with 16 stocks rising over 10%, including Honglida and Zhongke Lanyun, which hit the daily limit [1] - The turnover rate distribution shows that 2 stocks had a turnover rate exceeding 20%, 21 stocks between 10% and 20%, and 83 stocks between 5% and 10% [1] Stock Highlights - The stock with the highest turnover rate was Lianyun Technology, which closed up 9.43% with a turnover rate of 25.52% and a transaction amount of 980 million yuan [1] - Zhongke Lanyun also hit the daily limit with a closing price increase of 20.00% and a turnover rate of 24.47%, with a transaction amount of 1.448 billion yuan [1] - Other notable stocks with high turnover rates include Canxin Technology, Zhenlei Technology, and Huahai Chengke, with turnover rates of 18.59%, 15.09%, and 15.07% respectively [1] Sector Analysis - In terms of sector performance, the electronics sector had the most stocks with a turnover rate exceeding 5%, totaling 50 stocks, followed by machinery and equipment, and computer sectors, each with 15 stocks [2] - Among the high turnover stocks, 56 experienced net inflows of main funds, with the highest net inflows seen in SMIC, Chipone, and Dongxin, amounting to 508 million yuan, 483 million yuan, and 241 million yuan respectively [2] Leverage Fund Movements - A total of 78 stocks received net purchases from leveraged funds, with significant increases in financing balances observed in SMIC, Dekeli, and Juguang Technology, which increased by 2.056 billion yuan, 479 million yuan, and 216 million yuan respectively [2] - Conversely, stocks like Kaipu Cloud, Huahong Company, and Aerospace Hongtu saw significant decreases in financing balances, with reductions of 94.232 million yuan, 86.227 million yuan, and 64.006 million yuan respectively [2]

Market Overview - The main funds in the Shanghai and Shenzhen markets experienced a net outflow of 18.892 billion yuan, while the Sci-Tech Innovation Board saw a net inflow of 731 million yuan [1] - A total of 217 stocks on the Sci-Tech Innovation Board had net inflows, while 370 stocks had net outflows [1] Sci-Tech Innovation Board Performance - On the Sci-Tech Innovation Board, 363 stocks rose, with two stocks, Honglida and Zhongke Lanyun, hitting the daily limit, while 215 stocks declined [1] - The top three stocks with the highest net inflow of funds were Haiguang Information (1.264 billion yuan), SMIC (508 million yuan), and Chipone (483 million yuan) [1][2] Continuous Fund Flow - There are 44 stocks with continuous net inflows for more than three trading days, with Cambrian leading at 24 consecutive days of inflow [2] - Conversely, 179 stocks experienced continuous net outflows, with Naike Equipment showing the longest streak at 17 consecutive days [2] Top Fund Inflows - The top stocks by net inflow include: - Haiguang Information: 1263.65 million yuan, with a flow rate of 6.95% and a price increase of 10.70% [2] - SMIC: 507.74 million yuan, with a flow rate of 2.56% and a price increase of 6.25% [2] - Chipone: 483.24 million yuan, with a flow rate of 5.98% and a price increase of 17.34% [2] Notable Outflows - The stock with the highest net outflow was Borui Pharmaceutical, which saw a decline of 13.15% and a net outflow of 367 million yuan [1] - Other notable outflows included Dekeli and Juguang Technology, with net outflows of 235 million yuan and 184 million yuan, respectively [1]

炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ 第1笔成交价格为81.80元，成交2.61万股，成交金额213.50万元，溢价率为0.00%，买方营业部为申万宏 源证券有限公司证券投资总部，卖方营业部为国联民生证券股份有限公司总部。 进一步统计，近3个月内该股累计发生23笔大宗交易，合计成交金额为2.2亿元。该股近5个交易日累计 下跌10.29%，主力资金合计净流入1.62亿元。 责任编辑：小浪快报 9月22日，博瑞医药（维权）收跌13.15%，收盘价为81.80元，发生1笔大宗交易，合计成交量2.61万 股，成交金额213.5万元。 ...

| 交易日期 | | 证券代码 > | 成交价(元) 成交盒额[万元) 成交量(*) 买入营业部 | | 美出营业部 | 是否为专场 | | --- | --- | --- | --- | --- | --- | --- | | 025-09-22 | 博瑞医药 | 688166 | 81.8 213.5 2.61 | 患否查雾墙落复露 | 要聚民需要服務 | KO | 9月22日，博瑞医药大宗交易成交2.61万股，成交额213.5万元，占当日总成交额的0.06%，成交价81.8 元，较市场收盘价81.8元持平。 ...

东吴证券股份有限公司研究员朱国广9月16日发布研报《博瑞医药(688166)：BGM0504片剂中美均进入I 期临床在研管线顺利推进》称，维持博瑞医药"买入"评级。 中国经济网北京9月22日讯博瑞医药(688166.SH)股价今日下跌，截至收盘报81.80元，跌幅13.15%。 ...

北京商报讯（记者 丁宁）9月22日午后，博瑞医药（688166）股价跳水回落，盘中一度跌逾10%。 交易行情显示，博瑞医药9月22日高开0.47%，盘中一度涨逾8%。截至北京商报发稿，博瑞医药报84.63 元/股，跌幅为10.15%。当日振幅达21.88%。 ...

格隆汇9月22日｜A股市场减肥药概念股走弱，其中，博瑞医药跌近10%，众生药业跌超8%，普洛药 业、普蕊斯跌超3%。 ...

Group 1 - The core viewpoint of the news is that the weight loss drug sector experienced a significant decline in stock prices after an initial rise, indicating volatility in this market segment [1] - Specifically, Borui Pharmaceutical saw a drop of over 10% after previously rising more than 9% [1] - Other companies in the sector, such as Zhongsheng Pharmaceutical, fell over 7%, while Tianenkang, Kexing Pharmaceutical, Baihua Pharmaceutical, and Jinkaishengke also experienced declines [1]

Market Overview - The Shanghai Composite Index fell by 0.30% on September 19, with 16 industries rising, led by coal and non-ferrous metals, which increased by 1.97% and 1.19% respectively [2] - The automotive and pharmaceutical industries experienced the largest declines, with drops of 1.94% and 1.41% respectively [2] Capital Flow Analysis - The main capital outflow from the two markets totaled 58.733 billion yuan, with 8 industries seeing net inflows [2] - The non-ferrous metals industry had the highest net inflow, amounting to 872 million yuan, while the media industry followed with a net inflow of 692 million yuan and a daily increase of 0.49% [2] - A total of 23 industries experienced net capital outflows, with the computer industry leading at 10.723 billion yuan, followed by the automotive industry with 7.929 billion yuan [2] Pharmaceutical Industry Performance - The pharmaceutical industry saw a decline of 1.41% with a total net capital outflow of 7.085 billion yuan [3] - Out of 474 stocks in the pharmaceutical sector, 65 stocks rose while 405 stocks fell, including one stock hitting the daily limit down [3] - The top three stocks with the highest net inflow in the pharmaceutical sector were: - Borui Pharmaceutical with a net inflow of 130 million yuan - Mindray Medical with 75.259 million yuan - Micron Technology with 73.759 million yuan [3][4] Capital Outflow in Pharmaceutical Sector - The stocks with the largest capital outflows included: - China National Pharmaceutical with a net outflow of 406 million yuan - Furuya Shares with 342 million yuan - Xingqi Eye Medicine with 188 million yuan [5] - Other notable outflows included: - Hengrui Medicine with a net outflow of 172 million yuan - Celgene Medical with 158 million yuan [5][6]